HLA-DOB and myeloid sarcoma: By contrast, the logFc of HLA-DOB (ID 205671_s_at, adjusted p = 1.06E-04) was 1.57, indicating that the expression of HLA-DOB in MS cases was 3.0-fold higher (upregulated) in MS cases in contrast with control subjects (Table 2).